Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data

Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Value in health 2014-11, Vol.17 (7), p.A400-A401
Hauptverfasser: Bergvall, N, Lahoz, R, Nazareth, T, Korn, J.R
Format: Artikel
Sprache:eng
Schlagworte:
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A401
container_issue 7
container_start_page A400
container_title Value in health
container_volume 17
creator Bergvall, N
Lahoz, R
Nazareth, T
Korn, J.R
description
doi_str_mv 10.1016/j.jval.2014.08.912
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790465306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1098301514028423</els_id><sourcerecordid>1790465306</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2472-1c0cc7ca461f8f56d553a990555d9d2243ca97dcf2b12de49c8097063de59e553</originalsourceid><addsrcrecordid>eNo9UU1v1DAUtBCIloU_wAH5yCXBduwk5oBUtSwgFXXFAlfLdV5YL84HsbMo_4KfzIu2cPKTPTPPM0PIS85yznj55pgfTzbkgnGZszrXXDwil1wJmcmqKB7jzHSdFYyrC_IsxiNjrCyEekouRCUY00pckj87mKKPCXoH9LdPB7r1_Y8h-G5o6Hd8myO98R2kwxLodu7sZBNQ39OdTR76FM-kz3NIfgxA9y7ANKDiW_oFEk4juORPQK96Gxa8p0NLUfNuhD7bD_OEa3cHO3XWLfTGJvucPGltiPDi4dyQb9v3X68_Zrd3Hz5dX91mTshKZNwx5ypnZcnbulVlo1RhtWZKqUY3QsjCWV01rhX3XDQgtauZrtB_A0oDgjfk9Vl3nIZfM8RkOh8dhGB7GOZoeKWZLFWBlA0RZ6hDP3GC1oyTxyQWw5lZmzBHszZh1iYMqw02gaRXD_rzfQfNf8q_6BHw7gwAdHnyMBkXfO-dDT9hgXjEbDAy_IiJwjCzX8tcu-SSiVqKovgLvdmcqw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790465306</pqid></control><display><type>article</type><title>Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data</title><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bergvall, N ; Lahoz, R ; Nazareth, T ; Korn, J.R</creator><creatorcontrib>Bergvall, N ; Lahoz, R ; Nazareth, T ; Korn, J.R</creatorcontrib><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2014.08.912</identifier><identifier>PMID: 27200952</identifier><language>eng</language><publisher>United States</publisher><subject>Internal Medicine</subject><ispartof>Value in health, 2014-11, Vol.17 (7), p.A400-A401</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2472-1c0cc7ca461f8f56d553a990555d9d2243ca97dcf2b12de49c8097063de59e553</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27200952$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bergvall, N</creatorcontrib><creatorcontrib>Lahoz, R</creatorcontrib><creatorcontrib>Nazareth, T</creatorcontrib><creatorcontrib>Korn, J.R</creatorcontrib><title>Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data</title><title>Value in health</title><addtitle>Value Health</addtitle><subject>Internal Medicine</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9UU1v1DAUtBCIloU_wAH5yCXBduwk5oBUtSwgFXXFAlfLdV5YL84HsbMo_4KfzIu2cPKTPTPPM0PIS85yznj55pgfTzbkgnGZszrXXDwil1wJmcmqKB7jzHSdFYyrC_IsxiNjrCyEekouRCUY00pckj87mKKPCXoH9LdPB7r1_Y8h-G5o6Hd8myO98R2kwxLodu7sZBNQ39OdTR76FM-kz3NIfgxA9y7ANKDiW_oFEk4juORPQK96Gxa8p0NLUfNuhD7bD_OEa3cHO3XWLfTGJvucPGltiPDi4dyQb9v3X68_Zrd3Hz5dX91mTshKZNwx5ypnZcnbulVlo1RhtWZKqUY3QsjCWV01rhX3XDQgtauZrtB_A0oDgjfk9Vl3nIZfM8RkOh8dhGB7GOZoeKWZLFWBlA0RZ6hDP3GC1oyTxyQWw5lZmzBHszZh1iYMqw02gaRXD_rzfQfNf8q_6BHw7gwAdHnyMBkXfO-dDT9hgXjEbDAy_IiJwjCzX8tcu-SSiVqKovgLvdmcqw</recordid><startdate>201411</startdate><enddate>201411</enddate><creator>Bergvall, N</creator><creator>Lahoz, R</creator><creator>Nazareth, T</creator><creator>Korn, J.R</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201411</creationdate><title>Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data</title><author>Bergvall, N ; Lahoz, R ; Nazareth, T ; Korn, J.R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2472-1c0cc7ca461f8f56d553a990555d9d2243ca97dcf2b12de49c8097063de59e553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Internal Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bergvall, N</creatorcontrib><creatorcontrib>Lahoz, R</creatorcontrib><creatorcontrib>Nazareth, T</creatorcontrib><creatorcontrib>Korn, J.R</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bergvall, N</au><au>Lahoz, R</au><au>Nazareth, T</au><au>Korn, J.R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data</atitle><jtitle>Value in health</jtitle><addtitle>Value Health</addtitle><date>2014-11</date><risdate>2014</risdate><volume>17</volume><issue>7</issue><spage>A400</spage><epage>A401</epage><pages>A400-A401</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><cop>United States</cop><pmid>27200952</pmid><doi>10.1016/j.jval.2014.08.912</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1098-3015
ispartof Value in health, 2014-11, Vol.17 (7), p.A400-A401
issn 1098-3015
1524-4733
language eng
recordid cdi_proquest_miscellaneous_1790465306
source ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals
subjects Internal Medicine
title Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A52%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Persistence%20with%20Fingolimod%20Versus%20Dimethyl%20Fumarate%20in%20Patients%20with%20Multiple%20Sclerosis:%20Retrospective%20Analysis%20of%20us%20Open-Source%20Pharmacy%20Data&rft.jtitle=Value%20in%20health&rft.au=Bergvall,%20N&rft.date=2014-11&rft.volume=17&rft.issue=7&rft.spage=A400&rft.epage=A401&rft.pages=A400-A401&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2014.08.912&rft_dat=%3Cproquest_cross%3E1790465306%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1790465306&rft_id=info:pmid/27200952&rft_els_id=1_s2_0_S1098301514028423&rfr_iscdi=true